UC2GM141587

Spad at Alaska Pacific University - 1 spad for Alaska Pacific University 2 project summary/abstract 3. Under the global goal of providing the foundation for research administration support to ensure that Alaska Native/American Indian professional in biomedical fields succeed in their sponsored projects funding pursuits, Alaska Pacific University seeks to increase productivity of sponsored programs activities; enhance biomedical research and training at APU; and enhance faculty and student participation in biomedical research and research training programs, especially among indigenous students. As an Alaska Native-serving institution with a unique affiliation with the Alaska Native Tribal Health Consortium, the largest, most comprehensive tribal health organization in the United States, APU has very recently built an office of sponsored programs. With emerging undergraduate research programs in biomedical sciences, the institution is ideally positioned to leverage NIH spad support to further develop OSP into an effective, efficient, and sustainable unit of support to the university research community. Specific aims/objectives include: 1) increase # of proposal application submission and # of awards over AY20 baseline; 2) enhance research community understanding of regulatory compliance areas through training, education and development; and 3) enhance research community understanding of/response to the indigenous communities APU serves, conduct training, education and development on the lifecycle of sponsored projects.

Alaska Pacific University

NOT APPLICABLE

93.310 - Trans-NIH Research Support

National Institute of General Medical Sciences (NIGMS) [HHS - NIH]

National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]

Alaska United States

State-Wide

Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not Allowed) (RFA-RM-19-004)

Amendment Since initial award the End Date has been extended from 04/30/24 to 04/30/25 and the total obligations have increased 200% from $280,000 to $840,000.